VEPTP inhibition with an extracellular domain targeting antibody did not restore albuminuria in a mouse model of diabetic kidney disease.
Saved in:
| Title: | VEPTP inhibition with an extracellular domain targeting antibody did not restore albuminuria in a mouse model of diabetic kidney disease. |
|---|---|
| Authors: | Rana R; Cardiovascular and Metabolism, Johnson & Johnson Research & Development, Spring House, Pennsylvania, USA.; Cardiovascular and Metabolism, Johnson & Johnson Research & Development, Cambridge, Massachusetts, USA., Natoli TA; Cardiovascular and Metabolism, Johnson & Johnson Research & Development, Spring House, Pennsylvania, USA.; Cardiovascular and Metabolism, Johnson & Johnson Research & Development, Cambridge, Massachusetts, USA., Khandelwal P; Biologics Discovery, Johnson & Johnson Research & Development, Spring House, Pennsylvania, USA., Pissios P; Cardiovascular and Metabolism, Johnson & Johnson Research & Development, Spring House, Pennsylvania, USA.; Cardiovascular and Metabolism, Johnson & Johnson Research & Development, Cambridge, Massachusetts, USA., Muhammad AB; Cardiovascular and Metabolism, Johnson & Johnson Research & Development, Spring House, Pennsylvania, USA.; Cardiovascular and Metabolism, Johnson & Johnson Research & Development, Cambridge, Massachusetts, USA., Chipashvili V; Cardiovascular and Metabolism, Johnson & Johnson Research & Development, Spring House, Pennsylvania, USA.; Cardiovascular and Metabolism, Johnson & Johnson Research & Development, Cambridge, Massachusetts, USA., Farrington KP; Cardiovascular and Metabolism, Johnson & Johnson Research & Development, Spring House, Pennsylvania, USA.; Cardiovascular and Metabolism, Johnson & Johnson Research & Development, Cambridge, Massachusetts, USA., Zhou W; Cardiovascular and Metabolism, Johnson & Johnson Research & Development, Spring House, Pennsylvania, USA.; Cardiovascular and Metabolism, Johnson & Johnson Research & Development, Cambridge, Massachusetts, USA., Zheng G; Cardiovascular and Metabolism, Johnson & Johnson Research & Development, Spring House, Pennsylvania, USA.; Cardiovascular and Metabolism, Johnson & Johnson Research & Development, Cambridge, Massachusetts, USA., Bukanov NO; Cardiovascular and Metabolism, Johnson & Johnson Research & Development, Spring House, Pennsylvania, USA.; Cardiovascular and Metabolism, Johnson & Johnson Research & Development, Cambridge, Massachusetts, USA., Pocai A; Cardiovascular and Metabolism, Johnson & Johnson Research & Development, Spring House, Pennsylvania, USA.; Cardiovascular and Metabolism, Johnson & Johnson Research & Development, Cambridge, Massachusetts, USA., Magnone MC; Cardiovascular and Metabolism, Johnson & Johnson Research & Development, Spring House, Pennsylvania, USA.; Cardiovascular and Metabolism, Johnson & Johnson Research & Development, Cambridge, Massachusetts, USA. |
| Source: | Physiological reports [Physiol Rep] 2024 Sep; Vol. 12 (18), pp. e70058. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: published by Wiley Periodicals, Inc. on behalf of the American Physiological Society and The Physiological Society Country of Publication: United States NLM ID: 101607800 Publication Model: Print Cited Medium: Internet ISSN: 2051-817X (Electronic) Linking ISSN: 2051817X NLM ISO Abbreviation: Physiol Rep Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2051-817X |
|---|---|
| DOI: | 10.14814/phy2.70058 |
